SEATTLE, May 31, 2017 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an agreement to sell 2,750,000 shares of its common stock to Robert W. Baird & Co. Incorporated as the underwriter in an underwritten public offering pursuant to NanoString’s existing shelf registration statement. NanoString has also granted the underwriter a 30-day option to purchase up to an additional 412,500 shares of common stock. NanoString intends to use the net proceeds of the offering for general corporate purposes and working capital.
Robert W. Baird & Co. Incorporated is serving as sole underwriter for the offering.
A shelf registration statement on Form S-3 relating to the common stock offered in the public offering described above was filed with the Securities and Exchange Commission (SEC) on August 29, 2014 and declared effective by the SEC on September 10, 2014. The offering will be made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Copies of the preliminary prospectus supplement and the accompanying prospectus, when available, may also be obtained by contacting Robert W. Baird & Co. Incorporated, Attn: Syndicate Department, 777 East Wisconsin Avenue, Milwaukee, Wisconsin 53202, Telephone: (800) 792-2473, Email: [email protected].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of the securities being offered in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
Contact Douglas Farrell Vice President, Investor Relations & Corporate Communications [email protected] Phone: 206-602-1768


Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban
CATL Stock Hits Record High After Q1 2025 Earnings Surge
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear 



